PH
Université Jean Monnet Saint-Étienne, CHU Saint-Étienne, Centre de traitement de l'hémophilie, Mines Saint-Etienne, INSERM, SAINBIOSE U1059, F-42023 SAINT-ÉTIENNE, FRANCE
St Etienne, Rhone-Alpes, France
Brigitte Tardy, MD PhD, Dr, University hospital in Saint-Etienne, in France. She is involved in haemophilia care and is especially interested in the role of TFPI in the haemostatic balance and also in the anti-TFPI molecules as a prophylactic treatment of haemarraghia in the haemophilia patients. She is also interested in the bone loss in haemophilia patients and she is currently conducting a multicentric european study (PHILEOS) on osteoporosis prevalence in haemophilia patients regarding the severity and the type of haemophilia and the age at which the prophylactic treatment was began.
PB1061 - Impact of FII, FVIII, or FIX deficiency on bone mineralization in a zebrafish model
Tuesday, June 27, 2023
18:30 – 19:30 ET
OC 75.2 - Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest Study
Wednesday, June 28, 2023
10:30 – 10:45 ET